治療抵抗性がんの主要因を解明(Scientists Uncover Key Driver of Treatment-Resistant Cancer)

ad

2025-12-11 カリフォルニア大学サンディエゴ校(UCSD)

カリフォルニア大学サンディエゴ校(UC San Diego)の研究チームは、がん細胞が治療抵抗性を獲得する過程に関わる重要な酵素を発見した。がんの進行と治療抵抗性に関与するとされる「クロモスプリシス(chromothripsis)」は、染色体が一度に粉砕・再配置され、大量のゲノム変異を生み出す現象であり、がんの急速な進化を促す主要因の一つとして注目されているが、その引き金となる分子は長年不明だった。今回の研究で、酵素「N4BP2」が微小核(micronuclei)に侵入してDNAを切断し、クロモスプリシスを実際に引き起こすことが示された。 N4BP2を除去すると染色体破砕が大幅に減少し、逆に核内に導入すると正常細胞でも破砕が起きた。また、がんゲノム解析では N4BP2の高発現は構造変異や治療抵抗性に関連し、治療抵抗性や侵攻性を助長するエクストラクロモソームDNA(ecDNA)の増加にも関与することがわかった。この発見は、治療抵抗性がんに対する新たな分子標的治療戦略の可能性を拓く。

治療抵抗性がんの主要因を解明(Scientists Uncover Key Driver of Treatment-Resistant Cancer)

These images show the beginnings of chromothripsis in colorectal cancer cells. The N4BP2 enzyme (green) infiltrates a micronucleus (zoomed in square selections), where it induces DNA damage (red). Blue represents the main cell nucleus. Credit: UC San Diego Health Sciences

<関連情報>

細胞質に露出した染色体のN4BP2ヌクレアーゼによる断片化によって開始されるクロモトリプシスとecDNA Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes

Ksenia Krupina, Alexander Goginashvili, Michael W. Baughn, Stephen Moore, […] , and Don W. Cleveland
Science  Published:11 Dec 2025
DOI:https://doi.org/10.1126/science.ado0977

Editor’s summary

Massive genome rearrangements, or chromoanagenesis, are common in cancer and associated with poor prognosis. The most frequent form, chromothripsis, arises when one or more missegregated chromosomes form micronuclei that rupture, exposing their chromatin to the cytoplasm. Using an imaging-based small interfering RNA screen of human nucleases, Krupina et al. found that N4BP2, a previously uncharacterized cytoplasmic endonuclease, enters ruptured micronuclei and shatters chromosomes (see the Perspective by Clarke and Imieliński). N4BP2 was shown to promote the formation of extrachromosomal DNA and to enhance tumor growth in a human glioma model. Analysis of approximately 10,000 cancer genomes revealed that tumors with high N4BP2 expression were enriched for chromothripsis and copy number amplifications, implicating N4BP2 as a key driver of complex genome rearrangements. —Di Jiang

Abstract

Genome instability, including chromothripsis, is a hallmark of cancer. Cancer cells frequently contain micronuclei—small, nucleus-like structures formed by chromosome missegregation—that are susceptible to rupture, exposing chromatin to cytoplasmic nucleases. Through an unbiased, imaging-based small interfering RNA screen that targeted all 204 known and putative human nucleases, we identified a previously uncharacterized cytoplasmic endonuclease, NEDD4-binding protein 2 (N4BP2), that enters ruptured micronuclei and initiates DNA damage, leading to chromosome fragmentation. N4BP2 promoted genome rearrangements (including chromothripsis), formation of extrachromosomal DNA (ecDNA) in drug-induced gene amplification, tumorigenesis, and tumor cell proliferation in an induced model of human high-grade glioma. Analysis of more than 10,000 human cancer genomes revealed elevated N4BP2 expression to be predictive of chromothripsis and copy number amplifications, including ecDNA.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました